Related Experiment Video

Updated: Jul 8, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

DR negativity is a distinctive feature of M1/M2 AML cases with NPM1 mutation

Meilani Syampurnawati1, Eiji Tatsumi, Bambang Ardianto

  • 1International Center for Medical Research and Treatment (ICMRT), Graduate School of Medicine, Kobe University, Chuo-Ku, Kobe 650-0017, Japan.

Leukemia Research
|January 9, 2008
PubMed

Insights

The study found that NPM1 mutations are common in Deletional Refractory (DR(-)) Acute Myeloid Leukemia (AML), but absent in DR(+) AML. DR negativity is a key characteristic of AML with NPM1 mutations.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • FLT3-ITD mutations are more frequent in DR(-) M1/M2 AML compared to DR(+) M1/M2 AML.
  • DR(-) AML and AML with NPM1 mutation share common features like normal karyotype, CD34 absence, and FLT3-ITD presence.

Purpose of the Study:

  • To investigate the incidence of NPM1 mutations in DR(-) and DR(+) M1/M2 AML samples.
  • To determine if DR negativity is a phenotypic marker for AML with NPM1 mutation.

Main Methods:

  • Analysis of NPM1 mutation status in 54 AML samples (26 DR(-) and 28 DR(+)).
  • Correlation of NPM1 mutation status with FLT3-ITD and DR status.

Main Results:

  • NPM1 mutation was detected in 69.2% of DR(-) AML cases (18/26).
  • No NPM1 mutations were found in any DR(+) AML cases (0/28).
  • FLT3-ITD was present in 66.7% of cases with NPM1 mutation.

Conclusions:

  • DR negativity is a significant phenotypic characteristic associated with NPM1-mutated AML.
  • These findings support the classification of DR negativity as a marker for NPM1-mutated AML.

More Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Related Concept Videos

Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...